Artiva Biotherapeutics, Inc. — Cash Flow Charts
1 years of history · ending 2024-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-55M
Free Cash Flow
$-56M
Investing Cash Flow
$-120M
Financing Cash Flow
$162M
Capex
$642K
Stock-Based Comp
$7M
D&A
$2M
SBC Allocated Expense
$7M